Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/2003
12/11/2003CA2482639A1 3-substituted quinuclidines and their use
12/11/2003CA2482345A1 Compounds and compositions for the treatment of diabetes and diabetes-related disorders
12/11/2003CA2477261A1 Methods for enhancing motor performance and/or endurance
12/11/2003CA2454654A1 Pharmaceutically active compounds having a tricyclic pyrazolotriazolopyrimidine ring structure and methods of use
12/10/2003EP1369420A1 Inhibitors of the GPib - vWF interaction
12/10/2003EP1369419A1 N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same
12/10/2003EP1369418A1 Quinazoline derivatives
12/10/2003EP1369414A1 Enantiomerically pure Arylcycloalkyl hydroxycarboxylic esters, processes for their preparation and their use as modulators of muscarinic receptors
12/10/2003EP1369130A1 Process for producing sustained release preparation
12/10/2003EP1369129A1 Remedies for depression containing ep1 antagonist as the active ingredient
12/10/2003EP1369119A1 Il-12 expression controlling agents
12/10/2003EP1369115A1 Methods of preventing breast cancer by the administration of Raloxifene
12/10/2003EP1368494A2 Method and test system for identifying substances which protect nerve cells
12/10/2003EP1368477A1 Vaccine
12/10/2003EP1368470A2 Transcriptional mediators of blood vessel development and endothelial differentiation
12/10/2003EP1368469A2 Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof
12/10/2003EP1368381A1 2-alkylated-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block
12/10/2003EP1368378A2 Constitutively desensitized g protein-coupled receptors
12/10/2003EP1368372A2 Peptides having affinity for the gp120 viral protein and use thereof
12/10/2003EP1368364A1 C2, 8-disubstituted adenosine derivatives and their different uses
12/10/2003EP1368357A1 Tricyclic quinolinone and tricyclic quinoline as androgen receptor modulator compounds
12/10/2003EP1368356A2 N-but-3-enyl norbuprenorphine and its use as analgesic
12/10/2003EP1368354A1 Modulators of chemokine receptor activity
12/10/2003EP1368352A1 Cyclic guanosine 3',5'-monophosphate phosphodiesterase inhibitors
12/10/2003EP1368346A1 Substituted benzofuran-2-carboxamides derivatives
12/10/2003EP1368345A1 Alkoxycarbonylamino heteroaryl carboxylic acid derivatives as ip antagonists
12/10/2003EP1368344A1 Piperazine derivatives, their preparation and uses in therapy (5ht1b receptor activity)
12/10/2003EP1368341A1 Phenyl derivatives 3
12/10/2003EP1368340A1 Piperazine derivatives as melanocortin receptor agonists
12/10/2003EP1368337A2 Piperazine derivatives and their use as 5-ht1b ligands
12/10/2003EP1368336A2 Thiophene substituted amine derivatives as glyt-1 inhibitors
12/10/2003EP1368328A1 Methods for preparing new taxoids and pharmaceutical compositions containing them
12/10/2003EP1368327A1 Benzo thiadiazine matrix metalloproteinase inhibitors
12/10/2003EP1368324A1 Quinazolines as mmp-13 inhibitors
12/10/2003EP1368323A1 Pyrimidine matrix metalloproteinase inhibitors
12/10/2003EP1368322A2 New crystal forms of oxcarbazepine and processes for their preparation
12/10/2003EP1368319A1 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use as adenosine receptor-selective ligands
12/10/2003EP1368318A2 Calcilytic compounds
12/10/2003EP1368317A1 Tryptase inhibitors
12/10/2003EP1368313A1 Method for producing non-hydrated fexofenadine hydrochloride and a novel crystalline form obtained thereby
12/10/2003EP1368312A1 Benzo'f!isoindole derivatives with affinity to the ep4 receptor
12/10/2003EP1368306A1 Novel 1,2-diphenylethene derivatives for treatment of immune diseases
12/10/2003EP1368304A1 Prodrugs of excitatory amino acids
12/10/2003EP1368302A1 Novel amino dicarboxylic acid derivatives
12/10/2003EP1368300A1 Substituted amino dicarboxylic acid derivatives
12/10/2003EP1368296A1 Fluorinated trienes and their use as rxr modulators
12/10/2003EP1368094A1 4-(2-butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl) pyrazolo- 1,5-a]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands
12/10/2003EP1368060A1 Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases
12/10/2003EP1368054A2 Using neural thread proteins to treat tumors and other hyperproliferative disorders
12/10/2003EP1368053A2 Compositions and methods for treating gonadotrophin related illnesses
12/10/2003EP1368051A2 Urocortin-iii and uses thereof
12/10/2003EP1368040A2 Use of 5-substituted nucleosides and/or prodrugs thereof in the resistance-free treatment of infectious diseases
12/10/2003EP1368039A2 Aminoglycoside treatment for lysosomal storage diseases
12/10/2003EP1368038A1 Methods for the administration of amifostine and related compounds
12/10/2003EP1368037A2 Estrogen replacement therapy
12/10/2003EP1368036A1 Regulation of glucocorticoid concentration
12/10/2003EP1368034A1 Method and dosage form for treating tumors by the administration of tegafur, uracil, folinic acid, paclitaxel and carboplatin
12/10/2003EP1368032A1 Excitatory amino acid receptor antagonists
12/10/2003EP1368030A1 Epothilone derivatives for the treatment of refractory tumors
12/10/2003EP1368029A2 Method and composition for rejuvinating cells, tissues, organs, hair and nails
12/10/2003EP1368028A1 Benzimidazole compounds for modulating ige and inhibiting cellular proliferation
12/10/2003EP1368025A2 Compositions useful for the treatment of pathologies responding to the activation of ppar-gamma receptor
12/10/2003EP1368020A2 Method for identifying maxi-k channel blockers
12/10/2003EP1368019A1 Esmolol formulation
12/10/2003EP1368018A2 Use of sugar phosphate, sugar phosphate analogues, amino acids and/or amino acid analogues for modulating the glycolysis-enzyme complex, the malate-aspartate shuttle and/or transaminases
12/10/2003EP1368017A2 Compositions of biochemical compounds involved in bioenergy metabolism of cells and method of use
12/10/2003EP1368008A1 Transdermal therapeutic system for the administration of partial dopamine-d2 agonists
12/10/2003EP1367999A2 Water soluble and palatable complexes
12/10/2003EP1367995A1 Compositions and methods for enhancing drug delivery across and into epithelial tissues
12/10/2003EP1367982A2 Hair follicle neogenesis by injection of follicle progenitor cells
12/10/2003EP1367899A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
12/10/2003EP1289985B1 Beta-carboline derivatives useful as inhibitors of phosphodiesterase
12/10/2003EP1228058B1 Benzopyranyl guanidine derivatives, process for preparation thereof, and pharmaceutical compositions containing them
12/10/2003EP1189916B1 N-pyrazole a 2a receptor agonists
12/10/2003EP1163243B1 Calanolides for inhibiting btk
12/10/2003EP1148874B1 Use of anticonvulsant derivatives for treating bulimia nervosa
12/10/2003EP1140025B1 Granules for oral administration, process for producing the same, and tablets produced from the granules
12/10/2003EP1117403B1 Mglur5 antagonists for the treatment of pain and anxiety
12/10/2003EP1115721B1 Pyrimidone derivatives
12/10/2003EP1091953B1 Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
12/10/2003EP1039916B1 Use of at least one fucane for the manufacture of a medicament for the treatment of periodontal pathologies
12/10/2003EP0971885B1 Process for preparing indane-like compounds
12/10/2003EP0901374B1 Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders
12/10/2003EP0893995B1 Anticachectic composition
12/10/2003EP0862452B1 Stabilizing formulation for ngf
12/10/2003EP0825867B1 N,o-carboxymethylchitosan for prevention of surgical adhesions
12/10/2003EP0666914B1 Novel p-selectin ligand protein
12/10/2003EP0651759B1 Novel 2'-o-alkyl nucleosides and phosphoramidites processes for the preparation and uses thereof
12/10/2003CN1461304A Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists
12/10/2003CN1461303A Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists
12/10/2003CN1461222A Behavior chemotherapy
12/10/2003CN1461218A Therapeutic combination of amlodipine and benazepril
12/10/2003CN1461216A Compound for use as medicament for treatment of disorders involving bronchocontraction
12/10/2003CN1461214A Compositions for improving skin environment and clothes thereof
12/10/2003CN1460667A Pineapplie leaf extract, its preparation method and application
12/10/2003CN1460500A Fragrance body health-care product
12/10/2003CN1460479A New application of lactose derivative
12/10/2003CN1130365C Alpha-1 adrenergic compounds, drug composition containing same and their use
12/10/2003CN1130362C Nucleosides analogues, such as antivirals including inhititors of retroviral reverse transcriptase and DNA polymerase of heaptitis B virus (HBV)
12/10/2003CN1130358C Imidzzole compounds and preparing method and application thereof
1 ... 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 ... 1564